Pulse Biosciences (PLSE) FCF Margin (2021 - 2025)

Pulse Biosciences (PLSE) posted FCF Margin of 5628.79% for Q4 2025, up 63.05% on a QoQ basis from 15233.72% in Q3 2025.

Analysis

Pulse Biosciences (PLSE) FCF Margin (2021 - 2025) Analysis & Trends

Pulse Biosciences has reported FCF Margin for 3 years, with the latest figure at 5628.79% in Q4 2025.

On a quarterly basis, FCF Margin changed N/A year-over-year to 5628.79% in Q4 2025; TTM through Dec 2025 was 15553.43%, a N/A change from a year earlier, with the FY2025 full-year figure at 15553.43%, changed N/A from the prior year.
FCF Margin was 5628.79% for Q4 2025 at Pulse Biosciences, up from 15233.72% in the prior quarter.
The five-year high for FCF Margin was 88955.56% in Q4 2022, with the low at 15233.72% in Q3 2025.
Average FCF Margin over 3 years is 8052.1%, with a median of 3575.0% recorded in 2022.
The largest YoY upside for FCF Margin was 9047546 bps in 2022 against a maximum downside of 9047546 bps in 2022.
Over 3 years, FCF Margin stood at 1519.91% in 2021, then soared by 5953 bps to 88955.56% in 2022, then plunged by 106 bps to 5628.79% in 2025.
The last three FCF Margin figures came in at 5628.79% (Q4 2025), 15233.72% (Q3 2025), and 88955.56% (Q4 2022), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Abbott Laboratories	179.79 Bn	174.18 Bn	7.27 Bn	15.81%
2	Intuitive Surgical	127.69 Bn	122.47 Bn	1.96 Bn	32.79%
3	Medtronic	117.23 Bn	108.41 Bn	6.34 Bn	13.22%
4	Stryker	103.55 Bn	100.07 Bn	4.50 Bn	16.07%
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn	23.50%
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn	33.60%
7	Alcon	32.83 Bn	31.37 Bn	1.68 Bn	21.78%
8	Dexcom	32.30 Bn	30.35 Bn	830.00 Mn	14.10%
9	Steris	20.73 Bn	20.25 Bn	684.20 Mn	18.73%
10	Pulse Biosciences	3.76 Bn	3.76 Bn	161,000.00	-

Historic Data

Download Data